Sign up to save your podcasts
Or
Share Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial
In this podcast, Dr. Valentin Fuster discusses the Target for NA trial, which compares biodegradable polymer stents to second-generation drug-eluting stents for coronary intervention. While the results showed the biodegradable stents were non-inferior in preventing target lesion failure, questions remain regarding their real-world performance and procedural handling in clinical practice.
View all episodes
By American College of Cardiology
4.2
162162 ratings
In this podcast, Dr. Valentin Fuster discusses the Target for NA trial, which compares biodegradable polymer stents to second-generation drug-eluting stents for coronary intervention. While the results showed the biodegradable stents were non-inferior in preventing target lesion failure, questions remain regarding their real-world performance and procedural handling in clinical practice.
More shows like JACC This Week
View all
JAMA Editors' Summary
134 Listeners
NEJM This Week
321 Listeners
JAMA Clinical Reviews
504 Listeners
This Week in Cardiology
906 Listeners
JACC Specialty Journals
21 Listeners
Circulation on the Run
31 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
138 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
65 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
94 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Cardionerds: A Cardiology Podcast
437 Listeners